A Study to Evaluate Bioavailability of Rocatinlimab Autoinjector and Vial in Healthy Participants

NCT06438263 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

231

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis

Interventions

DRUG: Rocatinlimab
DRUG: Rocatinlimab

Sponsor

Amgen